Performance of blood coagulant CAS NO.0000-00-0

 1. Factory production, the price is more favorable, and conventional products are available from stock;

2. desheng is a professional manufacturer of a full set of blood vessel additives. There are a full set of blood vessel reagent products such as Heparin sodium, Heparin lithium, EDTAK2, EDTAK3, coagulant, silicifier, potassium oxalate, sodium fluoride, sodium citrate, etc.. More comprehensive services for you;

4.desheng has been doing for 14 years in the blood vessel collection industry. Our products are all self-developed and produced. We have the ability to solve most of the problems in blood vessel collection and provide customers with more secure services.

5.desheng started doing foreign trade in 2010. We have our own export rights.

Serum is one of the main samples for clinical biochemical and immune tests. At present, the main method for medical institutions to obtain serum samples is to collect venous blood and centrifuge it after the blood is completely coagulated. Now, under normal circumstances, the isolated blood samples need more than 60 minutes to complete coagulation, which is difficult to meet the needs of rapid detection in the laboratory. At present, the containers used by medical institutions to collect venous blood samples mainly include vacuum blood collection vessels or non vacuum containers after collecting blood samples with disposable syringes. The materials of the containers are divided into glass or plastic. At present, the coagulation process needs to include at least three basic biochemical reactions:

① Formation of prothrombin activator;

② Prothrombin activator changes prothrombin into active thrombin with the participation of calcium ions;

③ Soluble fibrinogen is transformed into insoluble fibrin under the action of thrombin. Visible blood clot formation is not only a physical phenomenon of fibrin formation, but also the end point of a series of enzymatic biochemical reactions. The whole process involves many coagulation factors. Under physiological conditions, coagulation factors are generally inactive. When these coagulation factors are activated, a series of enzymatic reactions of "waterfall theory of coagulation mechanism", which is still recognized today, are produced and lead to blood coagulation. Tissue factor, tissue thromboplastin or coagulation factor III, is the only coagulation factor that does not exist in animal blood. It belongs to lipoprotein, and its main component is phospholipid. It can catalyze the release of blood clotting factors in the brain tissue after blood clotting injury, and promote the release of blood clotting products in the blood clotting system. The main function of blood coagulant is to accelerate blood coagulation, that is, shorten the coagulation time of isolated blood without affecting the necessary components of blood, and promote the separation of serum.

The performance evaluation of blood coagulant should be considered from the following aspects:

1) Coagulation time: the time required for the blood to complete coagulation after contacting with the coagulant.

2) Coagulation efficiency: the relative amount of coagulant to be added to make the blood achieve the best coagulation effect.

3) Coagulation effect: the amount of serum exudation after blood coagulation.

4) Separation effect: whether the blood after coagulation promotion can achieve complete and clear serum separation and hemolysis after centrifugation.

5) Impact on essential components of blood: the use of coagulant can not have a harmful impact on the clinical test results of blood and the performance and quality of blood products.